MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,623 Cr | ₹2,177 Cr | ₹1,852 Cr | ₹1,491 Cr | ₹1,376 Cr |
What is the latest Revenue of MARKSANS PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,623 Cr |
| Mar2025 | ₹2,177 Cr |
| Mar2024 | ₹1,852 Cr |
| Mar2023 | ₹1,491 Cr |
| Mar2022 | ₹1,376 Cr |
How is Revenue of MARKSANS PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,623 Cr | 20.46 | |
| Mar2025 | ₹2,177 Cr | 17.56 | |
| Mar2024 | ₹1,852 Cr | 24.23 | |
| Mar2023 | ₹1,491 Cr | 8.33 | |
| Mar2022 | ₹1,376 Cr | - | |
Compare Revenue of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹13,738.8 Cr | -4.4% | -5% | 74.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -4.4% |
-5% |
74.9% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses